Skip to main content

Table 1 The identified 32 MDGs

From: A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes

MDGs

|Ai|

|Ti|

Pi

Di

T-i

T+i

TP53

15

8

< e-06

botha

BLCA BRCA HNSC LIHC

LUAD STAD UCEC

LGGa

PTEN

14

3

0.00147

both

LGG

STAD UCEC

RB1

11

2

0.00861

both

LGG

BLCA

PIK3CA

11

1

0.0277

hyper

 

STAD

ARID1A

10

1

0.0401

hyper

 

STAD

KRAS

8

1

1.2e-05

hypo

TGCT

 

KMT2D

8

2

0.00575

both

BLCA

STAD

NF1

6

2

0.000227

hypo

LGG PCPG

 

CTNNB1

6

2

0.00185

hypo

LIHC UCEC

 

SETD2

5

2

0.00351

hyper

 

KIRC KIRP

KMT2C b

5

1

0.00681

hyper

 

STAD

EGFR

4

1

9.5e-05

hypo

LGG

 

HRAS

4

2

0.000266

both

PCPG

HNSC

BRAF

4

2

0.00474

both

THCA

COAD

IDH1

3

2

< e-06

hyper

 

GBM LGG

CIC

3

1

1.3e-05

hyper

 

LGG

NRAS

3

2

1.4e-05

both

TGCT

THCA

RNF43

3

2

5.1e-05

both

STAD

COAD

ATRX

3

1

0.000487

hypera

 

LGGa

ZBTB20

3

2

0.00151

hyper

 

COAD STAD

NOTCH1

3

1

0.00189

hyper

 

LGG

CDH1

3

2

0.00213

hyper

 

BRCA STAD

KEAP1

3

1

0.00578

hypo

LUAD

 

SMARCA4

3

1

0.00687

hypo

LUAD

 

FOXA1 b

3

1

0.00953

hypo

PRAD

 

EPHA2 b

3

1

0.0104

hyper

 

STAD

KIT

2

1

< e-06

hypo

TGCT

 

KMT2B

2

2

0.000511

both

STAD

COAD

FGFR3 b

2

1

0.000697

hypo

BLCA

 

STK11 b

2

1

0.00193

hypo

LUAD

 

NSD1

1

1

< e-06

hypo

HNSC

 

BAP1 b

1

1

0.000142

hyper

 

LIHC

  1. |Ai|: number of tumor types in which CDG i is mutated in ≥ 5 samples with available methylation data;
  2. |Ti|: number of tumor types whose genome-wide methylation levels are significantly associated with the mutation status of CDG i;
  3. pi: p-value testing if CDG i is significantly associated with genome-wide methylation changes across tumor types;
  4. Di: direction of methylation changes associated with mutation status of CDG i;
  5. T+i: tumor types that are hyper-methylated by CDG i;
  6. T-i: tumor types that are hypo-methylated by CDG i;
  7. a: Further stratified analysis by IDH1 mutation status in LGG tumor samples suggests an opposite direction from hyper- to hypo-methylation;
  8. b: genes that are not overlapping driver genes
  9. __ : genes that are identified as associated with genome-wide patterns of aberrant methylation by Chen et al. [5]